Company: Foundation Medicine Inc.

FMI

Stock Code:

Enter Stock Code:

This report provides insider trading pattern and statistics for "Foundation Medicine Inc. (FMI)" . Please read important descriptions at the bottom of this report.

Register Free Insider Trade Email Alert for "Foundation Medicine Inc. (FMI)" !



 

Analysis & Screening

Chart Screening Tool

  Transaction Date

  Filing Date

Start Date:

Select Start Date

End Date:

Select End Date

Trading History Screening Tool

Transaction Code:

Ownership:

Share Class:

Trade Price From:

to

Transaction History From June 19th, 2017 To July 19th, 2017 (Max 50 Records Displayed)

Filing Date

Trade Date

 

Insider Name

Event Code

Ownership

Trade Information

Holding % Change

Jul 17/17

Jul 14/17

CxO Sell

Kafka Steven J.

President & COO

S

Direct ownership

Disposed -11,781 Common Stock at $39.15

-10.78%

Jul 17/17

Jul 13/17

CxO Sell

Ryan Jason

Chief Financial Officer

S

Direct ownership

Disposed -5,084 Common Stock at $39.77

-7.09%

Jul 07/17

Jul 06/17

CxO Sell

Daly David

Chief Commercial Officer

S

Direct ownership

Disposed -2,829 Common Stock at $38.84

-2.31%

Jul 07/17

Jul 06/17

CxO Sell

Daly David

Chief Commercial Officer

S

Direct ownership

Disposed -2,452 Common Stock at $38.84

-2.05%

Jul 07/17

Jul 06/17

CxO Sell

Daly David

Chief Commercial Officer

S

Direct ownership

Disposed -1,035 Common Stock at $38.84

-0.88%

Jul 07/17

Jul 06/17

CxO Sell

Hesslein Robert W.

SVP and General Counsel

S

Direct ownership

Disposed -3,372 Common Stock at $38.84

-2.69%

Jul 07/17

Jul 06/17

CxO Sell

Hesslein Robert W.

SVP and General Counsel

S

Direct ownership

Disposed -1,246 Common Stock at $38.84

-1.02%

Jul 07/17

Jul 06/17

CxO Sell

Hesslein Robert W.

SVP and General Counsel

S

Direct ownership

Disposed -452 Common Stock at $38.84

-0.37%

Jul 07/17

Jul 06/17

CxO Sell

Kafka Steven J.

President & COO

S

Direct ownership

Disposed -104 Common Stock at $38.84

-0.09%

Jul 07/17

Jul 06/17

CxO Sell

Kafka Steven J.

President & COO

S

Direct ownership

Disposed -4,284 Common Stock at $38.84

-3.67%

Jul 07/17

Jul 06/17

CxO Sell

Kafka Steven J.

President & COO

S

Direct ownership

Disposed -3,010 Common Stock at $38.84

-2.68%

Jul 07/17

Jul 06/17

Company Director Sell

Pellini Michael J

S

Direct ownership

Disposed -4,296 Common Stock at $38.84

-1.39%

Jul 07/17

Jul 06/17

Company Director Sell

Pellini Michael J

S

Direct ownership

Disposed -11,560 Common Stock at $38.84

-3.60%

Jul 07/17

Jul 06/17

CxO Sell

Ryan Jason

Chief Financial Officer

S

Direct ownership

Disposed -3,569 Common Stock at $38.84

-4.55%

Jul 07/17

Jul 06/17

CxO Sell

Ryan Jason

Chief Financial Officer

S

Direct ownership

Disposed -1,806 Common Stock at $38.84

-2.41%

Jul 07/17

Jul 06/17

CxO Sell

Ryan Jason

Chief Financial Officer

S

Direct ownership

Disposed -1,308 Common Stock at $38.84

-1.79%

Jul 07/17

Jul 06/17

CxO Sell

Miller Vincent A.

Chief Medical Officer

S

Direct ownership

Disposed -260 Common Stock at $38.84

-0.20%

Jul 07/17

Jul 06/17

CxO Sell

Miller Vincent A.

Chief Medical Officer

S

Direct ownership

Disposed -3,363 Common Stock at $38.84

-2.63%

Jul 07/17

Jul 06/17

CxO Sell

Miller Vincent A.

Chief Medical Officer

S

Direct ownership

Disposed -1,108 Common Stock at $38.84

-0.89%

Jul 07/17

Jul 06/17

CxO Sell

Miller Vincent A.

Chief Medical Officer

S

Direct ownership

Disposed -677 Common Stock at $38.84

-0.55%

Jul 07/17

Jul 05/17

CxO Sell

Kafka Steven J.

President & COO

S

Direct ownership

Disposed -12,310 Common Stock at $38.98

-9.54%

Jun 22/17

Jun 20/17

Company Director Buy

DOUGHERTY MICHAEL R

A

Direct ownership

Acquired 5,786 Common Stock at $40.05

30.45%

Jun 22/17

Jun 20/17

Company Director Buy

JONES EVAN/ FA

A

Direct ownership

Acquired 5,786 Common Stock at $40.05

29.27%

Jun 22/17

Jun 20/17

Company Director Buy

Yeshwant Krishna

A

Direct ownership

Acquired 5,786 Common Stock at $40.05

32.02%

Jun 22/17

Jun 20/17

Company Director Buy

Borisy Alexis

A

Direct ownership

Acquired 5,786 Common Stock at $40.05

8.59%

Company: Foundation Medicine Inc.

FMI

Stock Code:

Chart and trading summary tables represent transactions by company directors, chief executives(CEO, CFO, and senior company officers), corporate substantial shareholders, director's/executive's interest in affiliates of listed corporates, and individual substantial shareholders. Data on this page include all "Foundation Medicine Inc. (FMI)" securities traded or transferred within the specified date range defined in stock screening and analysis panel beside the chart. (Note that, not all corporate insiders will record their trading price or number of shares bought/sold in their filings. The missing data are not included in the trading summary calculation). Different insider symbols in the price chart represent transaction activities on a particular date (Not Stock Trading Price). Additionally, transaction price in chart and trading summary table are adjusted for foreign currency exchange rate on the best efforts. The trading summary in net stock buying or stock selling totals are done on a best efforts basis. All data presented should be treated as estimates as it is based on insider trade filings which are subject to errors if input mistakes are made by a filers. Mouse over on signals to see the transaction details in the transaction info box. The chart is optimized for IE5 or above.

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.